| Price | 8.30p on 15-09-2025 at 17:55:04 |
|---|---|
| Change | -0.70p -7.78% |
| Buy | 8.40p |
| Sell | 8.20p |
| Last Trade: | Buy 47,904.00 at 8.35p |
| Day's Volume: | 11,145,604 |
| Last Close: | 8.30p |
| Open: | 7.85p |
| ISIN: | GB00BYV81293 |
| Day's Range | 8.05p - 8.30p |
| 52wk Range: | 2.20p - 9.00p |
| Market Capitalisation: | £86.46m |
| VWAP: | 8.159168p |
| Shares in Issue: | 1.04b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 47,904 | 8.35p | Ordinary |
16:26:05 - 15-Sep-25 |
| Sell* | 20,000 | 8.23p | Ordinary |
16:19:01 - 15-Sep-25 |
| Buy* | 503 | 8.35p | Ordinary |
16:13:33 - 15-Sep-25 |
| Sell* | 25,000 | 8.23p | Ordinary |
16:08:53 - 15-Sep-25 |
| Buy* | 3,000 | 8.35p | Ordinary |
16:06:14 - 15-Sep-25 |
| Buy* | 35,928 | 8.35p | Ordinary |
16:05:39 - 15-Sep-25 |
| Sell* | 38,332 | 8.20p | Ordinary |
15:40:47 - 15-Sep-25 |
| Buy* | 11,947 | 8.37p | Ordinary |
15:33:40 - 15-Sep-25 |
| Sell* | 240 | 8.20p | SI Trade |
15:28:47 - 15-Sep-25 |
| Buy* | 1,337 | 8.40p | SI Trade |
15:28:47 - 15-Sep-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 4th Sep 2025 7:03 am | RNS | ACCRUFeR® assigned Priority Review in US by FDA |
| 3rd Sep 2025 2:17 pm | RNS | Interim results for the six months ended 30 Jun 25 |
| 27th Aug 2025 7:13 am | RNS | Data published -European Journal of Heart Failure |
| 21st Aug 2025 12:06 pm | RNS | Interim results for the six months ended 30 Jun 25 |
| 23rd Jul 2025 7:00 am | RNS | Q2 2025 Trading Update |
| 22nd May 2025 5:06 pm | RNS | Result of AGM |
| 24th Apr 2025 7:06 am | RNS | Audited results for the year ended 31 Dec 2024 |
| 22nd Apr 2025 7:01 am | RNS | Licence Agreement in Japan for ACCRUFeR® |
| 17th Apr 2025 11:23 am | RNS | Q1 2025 Trading Update |
| 11th Mar 2025 7:00 am | RNS | ACCRUFeR® launched in Canada |
